1. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Issue 2 (22nd August 2006) Authors: Capell, Hilary A; Madhok, Rajan; Porter, Duncan R; Munro, Robin A L; McInnes, Iain B; Hunter, John A; Steven, Malcolm; Zoma, Asad; Morrison, Elaine; Sambrook, Martin; Wui Poon, Fat; Hampson, Rosemary; McDonald, Fiona; Tierney, Ann; Henderson, Neil; Ford, Ian Journal: Annals of the rheumatic diseases Issue: Volume 66:Issue 2(2007) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. Issue 5 (1st May 1999) Authors: Gordon, Margaret-Mary; Porter, Duncan R; Capell, Hilary A Journal: Annals of the rheumatic diseases Issue: Volume 58:Issue 5(1999) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Step-up therapy remains an appropriate option. Issue 5 (9th February 2013) Authors: Porter, Duncan R Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 5(2013) Page Start: e6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗